Our people
Doug Frantz
As WashU’s vice chancellor for innovation and commercialization, Doug Frantz helps speed scientific discoveries into real-world therapies and devices. He works to develop strategic partnerships with industry and enhance WashU’s commercialization efforts.
Our expertise
Why prescription drug prices stay high — and what Congress can do about it
High prescription drug prices are not caused by any single company or practice, but by the system itself, said WashU Law’s Rachel Sachs. If Congress wants lower drug prices, it has to fix the structure and incentives of the entire supply chain, said Sachs, an expert on prescription drug pricing.
Engineered immune cells help reduce toxic proteins in the brain
Researchers at WashU Medicine and Weizmann Institute of Science designed a CAR-T cell therapy that reduced amyloid beta plaques in the brains of mice, pointing to a promising new approach for Alzheimer’s disease.
Our impact
WashU’s FARM hosts visit by international food, ag experts
Leaders from seven countries explored the WashU FARM initiative’s public health-driven research and global partnerships advancing sustainable, equitable food systems.
WashU recognized for its support of global research, international students
In recognition of its work to address complex global challenges and support international students and scholars, Washington University in St. Louis is a 2026 recipient of the Paul Simon Award for Campus Internationalization from NAFSA: Association of International Educators.
Videos
A scientist’s ‘a-ha moment’
Alex Quillin, PhD ’25, talks about the day she looked through the microscope and realized what she and her fellow students discovered.
